Indication
Abnormal uterine bleeding
Abnormal uterine bleeding is a broad clinical condition characterized by bleeding from the uterine corpus that departs from normal parameters of frequency, regularity, duration, or volume in nonpregnant females of reproductive age. Read more about Abnormal uterine bleeding
2 drugs 2 manufacturers
Drugs that treat it
Common Abnormal uterine bleeding therapies.
PREMARIN (estrogens, conjugated)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAbnormal uterine bleeding is a broad clinical condition characterized by bleeding from the uterine corpus that departs from normal parameters of frequency, regularity, duration, or volume in nonpregnant females of reproductive age.
It affects the female reproductive system and can present acutely as severe hemorrhage requiring emergent hemodynamic stabilization, or chronically over a prolonged duration.
Pathophysiologically, it is categorized by the FIGO PALM-COEIN classification into structural etiologies—such as uterine polyps, adenomyosis, leiomyomas, and malignancy—and nonstructural etiologies, including coagulopathies, ovulatory dysfunction, primary endometrial disorders, and iatrogenic causes.
Clinically, these disruptions compromise local endometrial hemostasis or systemic endocrine signaling, frequently resulting in iron deficiency anemia and substantially diminished quality of life.
- nih.gov
Abnormal uterine bleeding is a broad clinical condition characterized by bleeding from the uterine corpus that departs from normal parameters of frequency, regularity, duration, or volume in nonpregnant females of reproductive age It affects the female reproductive system and can present acutely as severe hemorrhage requiring emergent hemodynamic stabilization, or chronically over a prolonged duration
- coreem.net
Abnormal uterine bleeding is a broad clinical condition characterized by bleeding from the uterine corpus that departs from normal parameters of frequency, regularity, duration, or volume in nonpregnant females of reproductive age
- nih.gov
It affects the female reproductive system and can present acutely as severe hemorrhage requiring emergent hemodynamic stabilization, or chronically over a prolonged duration
- nih.gov
Pathophysiologically, it is categorized by the FIGO PALM-COEIN classification into structural etiologies—such as uterine polyps, adenomyosis, leiomyomas, and malignancy—and nonstructural etiologies, including coagulopathies, ovulatory dysfunction, primary endometrial disorders, and iatrogenic causes
- nih.gov
Pathophysiologically, it is categorized by the FIGO PALM-COEIN classification into structural etiologies—such as uterine polyps, adenomyosis, leiomyomas, and malignancy—and nonstructural etiologies, including coagulopathies, ovulatory dysfunction, primary endometrial disorders, and iatrogenic causes Clinically, these disruptions compromise local endometrial hemostasis or systemic endocrine signaling, frequently resulting in iron deficiency anemia and substantially diminished quality of life
- obgproject.com
Clinically, these disruptions compromise local endometrial hemostasis or systemic endocrine signaling, frequently resulting in iron deficiency anemia and substantially diminished quality of life
Personalize your experience
Follow Abnormal uterine bleeding and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.